Insider Transactions in Q4 2022 at Ekso Bionics Holdings, Inc. (EKSO)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2022
|
Steven Sherman Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
242,679
+19.99%
|
-
|
|
Dec 04
2022
|
Steven Sherman Executive Chair |
SELL
Open market or private sale
|
Direct |
10,576
-1.43%
|
$10,576
$1.28 P/Share
|
|
Dec 04
2022
|
Steven Sherman Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
31,198
+4.05%
|
-
|
|
Dec 04
2022
|
Jason C Jones Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,007
+10.7%
|
-
|
|
Dec 04
2022
|
Stanley Stern Director |
BUY
Grant, award, or other acquisition
|
Direct |
87,787
+34.45%
|
-
|
|
Nov 21
2022
|
Steven Sherman Executive Chair |
SELL
Open market or private sale
|
Direct |
5,787
-0.81%
|
$5,787
$1.26 P/Share
|
|
Nov 21
2022
|
Steven Sherman Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
15,599
+2.14%
|
-
|
|
Nov 16
2022
|
Jerome Wong Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
723
-0.71%
|
$723
$1.28 P/Share
|
|
Nov 16
2022
|
Jason C Jones Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
782
-0.62%
|
$782
$1.28 P/Share
|
|
Oct 24
2022
|
Steven Sherman Executive Chair |
SELL
Open market or private sale
|
Direct |
5,921
-0.84%
|
$5,921
$1.29 P/Share
|
|
Oct 21
2022
|
Steven Sherman Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
15,600
+2.17%
|
-
|